{"name":"Xiamen Amoytop Biotech Co., Ltd.","slug":"xiamen-amoytop-biotech-co-ltd","ticker":"","exchange":"","domain":"xiamenamoytop.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"ACT100 Injection","genericName":"ACT100 Injection","slug":"act100-injection","indication":"Other","status":"phase_1"},{"name":"ACT500 tablets","genericName":"ACT500 tablets","slug":"act500-tablets","indication":"Other","status":"phase_1"},{"name":"Inpegsomatropin Injection","genericName":"Inpegsomatropin Injection","slug":"inpegsomatropin-injection","indication":"Growth hormone deficiency in children","status":"phase_3"},{"name":"rhG-CSF/PEG-rhG-CSF","genericName":"rhG-CSF/PEG-rhG-CSF","slug":"rhg-csf-peg-rhg-csf","indication":"Neutropenia in patients undergoing chemotherapy","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"YPEG-rhG-CSF","genericName":"YPEG-rhG-CSF","slug":"ypeg-rhg-csf","indication":"Prevention of infection in patients undergoing chemotherapy or bone marrow transplantation","status":"phase_3"},{"name":"Ypeginterferon alfa-2b","genericName":"Ypeginterferon alfa-2b","slug":"ypeginterferon-alfa-2b","indication":"Treatment of chronic hepatitis B","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"rhG-CSF+rhGM-CSF group","genericName":"rhG-CSF+rhGM-CSF group","slug":"rhg-csf-rhgm-csf-group","indication":"Chemotherapy-induced neutropenia","status":"marketed"}]}],"pipeline":[{"name":"YPEG-rhG-CSF","genericName":"YPEG-rhG-CSF","slug":"ypeg-rhg-csf","phase":"phase_3","mechanism":"PEG-rhG-CSF is a recombinant human granulocyte colony-stimulating factor (G-CSF) conjugated with polyethylene glycol (PEG), which helps stimulate the production of white blood cells.","indications":["Prevention of infection in patients undergoing chemotherapy or bone marrow transplantation"],"catalyst":""},{"name":"rhG-CSF+rhGM-CSF group","genericName":"rhG-CSF+rhGM-CSF group","slug":"rhg-csf-rhgm-csf-group","phase":"marketed","mechanism":"This combination of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) stimulates the production and activation of neutrophils and myeloid cells to enhance immune function and hematopoietic recovery.","indications":["Chemotherapy-induced neutropenia","Hematopoietic stem cell transplantation support","Bone marrow recovery enhancement"],"catalyst":""},{"name":"ACT100 Injection","genericName":"ACT100 Injection","slug":"act100-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACT500 tablets","genericName":"ACT500 tablets","slug":"act500-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Inpegsomatropin Injection","genericName":"Inpegsomatropin Injection","slug":"inpegsomatropin-injection","phase":"phase_3","mechanism":"Inpegsomatropin is a long-acting growth hormone analog that binds to growth hormone receptors to promote growth, metabolism, and body composition changes.","indications":["Growth hormone deficiency in children","Growth hormone deficiency in adults"],"catalyst":""},{"name":"Ypeginterferon alfa-2b","genericName":"Ypeginterferon alfa-2b","slug":"ypeginterferon-alfa-2b","phase":"phase_3","mechanism":"Ypeginterferon alfa-2b is a recombinant form of interferon alfa-2b used to modulate the immune system.","indications":["Treatment of chronic hepatitis B","Treatment of chronic hepatitis C"],"catalyst":""},{"name":"rhG-CSF/PEG-rhG-CSF","genericName":"rhG-CSF/PEG-rhG-CSF","slug":"rhg-csf-peg-rhg-csf","phase":"phase_3","mechanism":"rhG-CSF/PEG-rhG-CSF stimulates the production of white blood cells.","indications":["Neutropenia in patients undergoing chemotherapy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPclllRE04VDdZaWE0dXNCcmtiR3hJX1NnQ0M5OGVHVnZFdkNPUmd2blJMamV1aTYzLWJrOUJVZy1Ld3hneGFqU0hvY1lvVkFqS2NtQi1HVjRPLXRTcnhvVFI5Wm1POUllVXU3LWFfN2ZBNlVKZXYwd2ptbzJQaHNVRWpHWW1VbVlOcVlwcjBCYjBpd21TdWN1OTI0WUJ0aWxTclpGR3NPdWhpMGFDZzhjVWxrR3ltTlZJQXZzOXVqQ3huVUU?oc=5","date":"2026-04-03","type":"pipeline","source":"Markets Mojo","summary":"Xiamen Amoytop Biotech Hits Day High with Strong 3.09% Intraday Surge - Markets Mojo","headline":"Xiamen Amoytop Biotech Hits Day High with Strong 3.09% Intraday Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOM3VRdlkxUXdOZHdjcm5sLXNON3RYbVhxdEdSMnZia3lhM0dkRmtzZk83YS16WlczUUpST3lTSDBnLUNCU3M1VUkydWd4dFRHMFBGVWJJVUJVb0ItY0ZqclJIeTBqOTBEbmU5WnBUSUxhMDJoN041bE1KbElSTDlpZm0ta21rZUY1azhJVnk3Y3I2SERWWjI5WkhzU3RsQXhaMTV5U21sam8xQVk0RFVaLXUxanp1WTJPN3ozal8xeFd3NWc?oc=5","date":"2026-03-24","type":"pipeline","source":"Markets Mojo","summary":"Xiamen Amoytop Biotech Hits Day Low at CNY 63.90 Amid Price Pressure - Markets Mojo","headline":"Xiamen Amoytop Biotech Hits Day Low at CNY 63.90 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPLUVqRjJhSlYwR0o3SDY5ejFGNTVRWF9KSW51RnM3aDI4NmlSTlhGVFhrTHNjMXJjZ0JRUm1XRlhBbkpmcXlIR0VMeFZQbG5KY0RZQlkyOXMzSTZ3VnVDYThzaUNUR3BNN3FRUFdVckQ5eVM4ZlM0czVBQVV3ZnU5Y2pLWm9GVkFpWW9DQzA5ekFILU0yVGJhNkduTU5DdHdKaTFEb0xibmc3dGl1aGUtWTNCTW43NGFsSnpHdkpSU25tWmtJT29rbm02ZzRRWTdr?oc=5","date":"2026-03-05","type":"earnings","source":"Investing News Network","summary":"Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results - Investing News Network","headline":"Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQTlhEdWphZUJnRXBsOUFsNnpxVC1FNnhFdVpMZVAtc0toSENLbVF0TzdaNWxwa3Vfc2J5REFjT0FGR3ZkMzg3QTRxZWQtNDdDV1BCQ1o3LWJXdWs3S0ZFMW5hcXI5cC1sOFd2WUZSTmtYem5sbGtuTU82MWZydDdpUllFNmFCY0FlRGZPYlNJNjgxbjY1ckhUbW1WMFRGQnE5ZnYxamM3aWFlX3RMd255NlluRmVMbUllWVE?oc=5","date":"2026-03-05","type":"pipeline","source":"Stock Titan","summary":"Obesity drug combo from Aligos drives 40% weight loss in mice - Stock Titan","headline":"Obesity drug combo from Aligos drives 40% weight loss in mice","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-06","type":"pipeline","source":"simplywall.st","summary":"3 Asian Stocks Estimated To Be 35.9% To 49.2% Below Intrinsic Value - simplywall.st","headline":"3 Asian Stocks Estimated To Be 35.9% To 49.2% Below Intrinsic Value","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-29","type":"pipeline","source":"simplywall.st","summary":"3 Asian Stocks Possibly Undervalued By Up To 48.3% - simplywall.st","headline":"3 Asian Stocks Possibly Undervalued By Up To 48.3%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQY3VSRV83S1lfRXJkT3VURUxnbXh5MjF0NEdiMm45ZWtUN0FkS2NUVHRaS2NmeXQtbnNQMzN0RFRDVXFsS0dMUTMwMzQ4ajdsTTF0Rm9XQmVqLUFTM2tZS0cxQVVsaVFWYVlpSUR2aGx4bXJWQ0R6dUZDdzdNdEFGOHhoaDlpdmtVT2hSajlqVnV6Tno5MGdlZmZiVHVlYWp6QkRrVi1n?oc=5","date":"2025-07-18","type":"pipeline","source":"BioWorld News","summary":"Diamedica’s DM-199 shows promise for serious pregnancy disorder - BioWorld News","headline":"Diamedica’s DM-199 shows promise for serious pregnancy disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPZEJjRWFaTkktQlR0NVUxeVQxVW5TQ0JROUthaUwyVTczejlGYWprdkUtdTZxdVdyU1RkY0NQdDR3ZkFCNzNyYV9JdmsyLVJtaGxOWlpWQ3d2djN3akdkV3VqYXJKV0JWcl93eWtkekxOZ0FuLVduYktrZ2NtWnE5b2cxNy10LWswRnNscVd4S2tzd28zVVJZNkJEamtzWGRwVklXX0hQel9rQmF4di0yWmpXRkhOYUs3UjE1ZzFyUDNxcTV6eWhmcjF5QU1LS3JwR1BHVG5CT0ItQjg0NVBYQ25yNmJKUkRlZGRoWmdTSVljcHd4cHlmaGRTbWNZeDNGRl9QSU1oNFZJSWhuaFFaUlg1OTBlc0dRcmxZSmtDc2lLTS1hZnBMNlh2U2hqOEhzckE?oc=5","date":"2025-05-28","type":"pipeline","source":"BioSpace","summary":"Drug Farm and Xiamen Amoytop Biotech Co., Ltd. Enter into Option Agreement for First-In-Class Innate Immunity Agonist, DF-006 to Treat Hepatitis B and Hepatocellular Cancer - BioSpace","headline":"Drug Farm and Xiamen Amoytop Biotech Co., Ltd. Enter into Option Agreement for First-In-Class Innate Immunity Agonist, D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBlbmFMTTZQbjgwNFZzY25UdHR1VktFeDJPRjZiWGFNamI0NlFlZ0VrMWJBSGsyaDZNdHVJel82UkhwZGp5V0JFTXNTamdza1lSd1hB?oc=5","date":"2016-08-16","type":"pipeline","source":"Nature","summary":"Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model - Nature","headline":"Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":4,"marketed":1,"phase_1":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}